USPTO serial 99551675
PULSELOGIC
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBIN, DAVID I
- Law office
- TMEG LAW OFFICE 107
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 6, 2026
Need help with PULSELOGIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Office Action issues
The USPTO examiner found no conflicting marks, but requires clarification of your goods and services description, an explanation of your mark's significance, and your email address.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable medical software for analyzing multi-modal biomarker, gene expression, and clinical data to generate cancer risk stratification and prognosis scores; Downloadable medical software for collecting, analyzing, and organizing multi-omic biomarker, gene expression, genomic, imaging, and clinical data for cancer diagnostics, risk stratification, prognosis prediction, and treatment response assessment.; Downloadable computer software using artificial intelligence (AI) for medical data analysis and clinical decision support in the field of oncology..; Downloadable computer software for scientific analysis of genetic sequences and for structural and functional analysis of genomes. | ACTIVE | — |
| 042 | Providing on-line non-downloadable software using artificial intelligence (AI) for medical data analysis and clinical decision support.; Providing online non-downloadable software using machine learning for enabling computers to learn to perform medical data analysis and outcome prediction tasks autonomously in the field of oncology.; Providing on-line non-downloadable software for collecting, analyzing, and organizing medical, genomic, and biomarker data in the field of oncology and precision medicine.; Providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of patient medical records and cancer diagnostics on a secure database.; Providing online non-downloadable computer software platforms for application development, data integration, and database management in the field of oncology and precision medicine.; Providing an online non-downloadable Internet-based system application featuring technology enabling users to upload, store, curate, and analyze medical datasets, namely, genomics, clinical, imaging, and laboratory data, for use in cancer diagnostics and precision medicine.; Providing information relating to on-line non-downloadable software to facilitate electronic communication between individuals provided via the Internet; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for medical data analysis, cancer diagnostics, and precision medicine workflows.; Providing temporary use of on-line non-downloadable software development tools for integrating medical data analysis, biomarker fusion, and clinical decision support functionality into third-party healthcare applications.; Providing temporary use of on-line non-downloadable software for analyzing multi-omic biomarker data for cancer risk stratification, prognosis prediction, and treatment response assessment.; Providing temporary use of online non-downloadable computer software for collecting, analyzing and organizing data in the field of deep learning.; Providing temporary use of on-line non-downloadable software for synchronizing and managing medical databases containing genomics, clinical, and imaging data.; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for biomarker fusion, medical data modeling, and clinical decision support in the field of oncology.; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for medical data analysis, cancer risk stratification, prognosis prediction, and clinical decision support.; Providing temporary use of online non-downloadable computer software applications for collecting, analyzing and organizing data in the field of deep learning for medical diagnostics.; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for cancer diagnostics, biomarker fusion, and precision medicine workflows. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PulseLogic Biosciences, Inc.
- Other trademarks owned by FAR ROCKAWAY VENTURES IP LLC
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PULSELOGIC
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2025 | NWAP | NEW APPLICATION ENTERED | — |